Amgen Inc. (AMGN) Operating cash flow 2016–2025
Amgen Inc. (AMGN) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
$10.0BFY2025 · since FY2016: $10.4B → $10.0B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $10.0B | -13.3% |
| FY2024 | $11.5B | +35.6% |
| FY2023 | $8.5B | -12.9% |
| FY2022 | $9.7B | +5.0% |
| FY2021 | $9.3B | -11.8% |
| FY2020 | $10.5B | +14.7% |
| FY2019 | $9.2B | -19.0% |
| FY2018 | $11.3B | +1.1% |
| FY2017 | $11.2B | +7.9% |
| FY2016 | $10.4B | — |
Source: SEC XBRL filings · For reference only · Not investment advice